Jakavi.com

Website Ranking Data
Current Alexa Rank

56,390

Updated Jan 10 2023
Historical Rank
Estimated Visitors

55,002

Daily Unique Visitors

1,705,071

Monthly Visitors

20,460,852

Yearly Visitors
Domain Information
Registrar MARKMONITOR INC.
Created 24.05.2007
Updated 22.04.2013
Expiration 24.05.2015
Name Server Information
dns1.novartis.com
dns2.novartis.com
mia03-1.digex.com
Web Server Information
IP Address 217.114.92.50
Server Response 200
Web Server Microsoft-IIS/8.0
Top related sites:
Meta Tags and Data
Title
JAKAVI (ruxolitinib) a JAK1 & JAK2 Inhibitor for MF & PV Treatment | JAKAVI
Meta Description
JAKAVI is indicated for the treatment of adult patients with Myelofibrosis and adult patients with Polycythaemia Vera who are resistant to or intolerant of hydroxyurea
Meta Keywords
JAKAVI, ruxolitinib, polycythaemia vera, polycythemia vera, PV treatment, JAK1/JAK2 inhibitor, JAK inhibitor
Whois Information
Name
Domain Admin
Organization
Novartis AG
Street
P.O. Box CH-4002,
City
Basel
Postal Code
4002
Country
SWITZERLAND
Phone
12083895740
Server Response
Content-Encodinggzip
Cache-Controlprivate
Content-Typetext/html; charset=utf-8
ServerMicrosoft-IIS/8.0
VaryAccept-Encoding
X-AspNet-Version4.0.30319
X-AspNetMvc-Version5.1
X-Powered-ByASP.NET